The invention described relates to novel strains of lactic acid bacteria and to novel compositions containing strains not previously known to be useful in treatment of allergy. The composition may be in the form of foodstuffs or in the form of pharmaceutical compositions. The invention described how to screen the strains of lactic acid bacteria can regulate the immune balance between Th1 type and Th2 type.